Klaria Pharma Holding AB (6FN) Financial Statements
Klaria Pharma Holding AB Financial Overview
Klaria Pharma Holding AB's market cap is currently $12.10M. The company's EPS TTM is $-0.17; its P/E ratio is -3.24; Klaria Pharma Holding AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.00M | $ 2.25M | $ 8.45M | $ 5.87M | $ 6.11M |
| Gross Profit | $ -2.23M | $ 2.25M | $ 8.45M | $ 5.87M | $ -4.85M |
| Operating Income | $ -20.42M | $ -31.21M | $ -31.85M | $ -54.97M | $ -50.11M |
| EBITDA | $ -9.20M | $ -19.99M | $ -20.81M | $ -44.80M | $ -39.41M |
| Net Income | $ -38.90M | $ -47.75M | $ -35.78M | $ -63.77M | $ -53.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 342.00K | $ 598.00K | $ 1.25M | $ 16.76M | $ 25.49M |
| Total Assets | $ 40.77M | $ 57.27M | $ 72.95M | $ 120.27M | $ 118.31M |
| Total Debt | $ 0.00 | $ 23.07M | $ 18.93M | $ 17.09M | $ 31.72M |
| Net Debt | $ -342.00K | $ 22.47M | $ 17.68M | $ 324.00K | $ 6.23M |
| Total Liabilities | $ 44.65M | $ 53.96M | $ 31.81M | $ 44.19M | $ 48.89M |
| Stockholders' Equity | $ -3.88M | $ 3.31M | $ 41.13M | $ 76.08M | $ 69.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.04M | $ -11.94M | $ -3.37M | $ -49.77M | $ -24.80M |
| Operating Cash Flow | $ -35.04M | $ -11.94M | $ -9.06M | $ -49.73M | $ -24.80M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -42.00K | $ 0.00 |
| Financing Cash Flow | $ 34.78M | $ 11.27M | $ -6.46M | $ 41.06M | $ 19.04M |
Currency in SEK
